Matthew Kaplan
Stock Analyst at Ladenburg Thalmann
(2.75)
# 1,983
Out of 4,962 analysts
26
Total ratings
58.33%
Success rate
17.43%
Average return
Main Sectors:
Stocks Rated by Matthew Kaplan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UTHR United Therapeutics | Maintains: Buy | $319 → $344 | $312.23 | +10.18% | 9 | Oct 31, 2024 | |
| URGN UroGen Pharma | Maintains: Buy | $48 → $54 | $19.44 | +175.21% | 1 | Jun 14, 2024 | |
| TGTX TG Therapeutics | Maintains: Buy | $39 → $40 | $29.45 | +35.85% | 3 | May 2, 2024 | |
| LQDA Liquidia | Maintains: Buy | $15 → $30 | $26.84 | +11.77% | 2 | Dec 21, 2023 | |
| ARDX Ardelyx | Maintains: Buy | $7.5 → $8.5 | $6.11 | +39.12% | 4 | Aug 3, 2023 | |
| AVDL Avadel Pharmaceuticals | Maintains: Buy | $15 → $16 | $15.24 | +4.99% | 1 | May 2, 2023 | |
| KPRX Kiora Pharmaceuticals | Reiterates: Buy | $1,071 | $2.73 | +39,130.77% | 2 | Feb 8, 2023 | |
| XAIR Beyond Air | Maintains: Buy | $340 → $460 | $2.25 | +20,344.44% | 1 | Jun 29, 2022 | |
| LPCN Lipocine | Upgrades: Buy | $51 | $3.11 | +1,539.87% | 1 | Dec 10, 2020 | |
| COGT Cogent Biosciences | Initiates: Buy | $16 | $12.12 | +32.01% | 1 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $3.11 | +1,346.95% | 1 | Jan 22, 2020 |
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $319 → $344
Current: $312.23
Upside: +10.18%
UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $48 → $54
Current: $19.44
Upside: +175.21%
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39 → $40
Current: $29.45
Upside: +35.85%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15 → $30
Current: $26.84
Upside: +11.77%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5 → $8.5
Current: $6.11
Upside: +39.12%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15 → $16
Current: $15.24
Upside: +4.99%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $1,071
Current: $2.73
Upside: +39,130.77%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $340 → $460
Current: $2.25
Upside: +20,344.44%
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: $51
Current: $3.11
Upside: +1,539.87%
Cogent Biosciences
Oct 14, 2020
Initiates: Buy
Price Target: $16
Current: $12.12
Upside: +32.01%
Jan 22, 2020
Initiates: Buy
Price Target: $45
Current: $3.11
Upside: +1,346.95%